TITLE:
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

CONDITION:
Diabetes Mellitus, Non-Insulin-Dependent

INTERVENTION:
AC2993

SUMMARY:

      This is a multicenter, randomized, blinded, placebo-controlled study to assess the effects
      on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes.
      Patients will be randomized into one of two AC2993 treatment arms or to placebo treatment
      and will continue with their required existing diabetes medication (sulfonylurea) throughout
      the study.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 16 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Subjects with Type 2 diabetes mellitus

          -  Treated with a sulfonylurea at defined doses for at least 3 months prior to screening

          -  BMI= 27-45 kg/m2

          -  HbA1c value between 7.5% and 11%

        Exclusion Criteria:

          -  Treated with oral anti-diabetic medications other than a sulfonylurea within 3 months
             of screening

          -  Patients treated previously with AC2993

          -  Patients presently treated with insulin
      
